CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,352 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 917 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 2,816 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 2,669 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 5,267 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 8,929 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 45,425 shares (to pay taxes)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Accounting Officer gave up 388 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief of Staff gave up 751 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,399 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,432 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 1,677 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 1,351 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,419 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,074 shares (to pay taxes)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 18 of 104 · 2,077 filings